Evidence map›Paper›PMID 28052263›Full record

ArticleCell reports2017

Amplification of Adipogenic Commitment by VSTM2A.

Blandine Secco, Étienne Camiré, Marc-Antoine Brière, Alexandre Caron, Armande Billong, Yves Gélinas, Anne-Marie Lemay, Kevin M Tharp, Peter L Lee, Stéphane Gobeil and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  12. Article
  13. Control of adipogenic commitment by a STAT3-VSTM2A axis.American journal of physiology. Endocrinology and metabolism · 2021
    Article
  14. Article
  15. Natural Autoantibodies in Chronic Pulmonary Diseases.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Genetic and epigenetic control of adipose development.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Blandine SeccoCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Étienne CamiréCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Marc-Antoine BrièreCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Alexandre CaronCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Armande BillongCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Yves GélinasCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Anne-Marie LemayCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Kevin M TharpProgram for Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
Peter L LeeUniversity of Massachusetts Medical School, Program in Molecular Medicine, Worcester, MA 01605, USA.
Stéphane GobeilCentre hospitalier universitaire de Québec (CHU de Québec), Université Laval, Faculté de médecine, 2705 Boulevard Laurier, QC G1V 4G2, Canada.
Jean V GuimondCIUSSS du Centre-Sud-de-l'ile-de-Montréal, CLSC des Faubourgs, 66 rue Sainte-Catherine Est, Montréal, QC H2X 1K6, Canada.
Natacha PateyCentre Hospitalier Universitaire de Sainte-Justine (CHU de Sainte-Justine), Faculté de Médecine, Département de pathologie et biologie cellulaire, Université de Montréal, 3175 Chemin Côte Ste-Catherine, Montréal, QC H3T 1C5, Canada.
David A GuertinUniversity of Massachusetts Medical School, Program in Molecular Medicine, Worcester, MA 01605, USA.
Andreas StahlProgram for Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
Élie HaddadCentre Hospitalier Universitaire de Sainte-Justine (CHU de Sainte-Justine), Faculté de Médecine, Département de pédiatrie et Département de microbiologie, infectiologie et immunologie, Université de Montréal, 3175 Chemin Côte Ste-Catherine, Montréal, QC H3T 1C5, Canada.
David MarsolaisCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Yohan BosséCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada.
Kivanc BirsoyLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.
Mathieu LaplanteCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Université Laval, Faculté de médecine, 2725 Chemin Ste-Foy, QC G1V 4G5, Canada. Electronic address: mathieu.laplante@criucpq.ulaval.ca.
Institut Universitaire de Cardiologie et de Pneumologie de Québec · CAUniversité Laval · CAUniversity of California, Berkeley · USUniversity of Massachusetts Chan Medical School · USCentre Hospitalier Universitaire Sainte-Justine · CACentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CARockefeller University · USUniversité de Montréal · CA

Funding

Mechanistic Target of Rapamycin Pathways in Metabolism and Energy ExpenditureR01DK094004 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GUERTIN, DAVID A · 2013 to 2023
$4.5M
Elucidating the AKT-dependent and AKT-independent mechanisms of metabolic control by mTORC2R01CA196986 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GUERTIN, DAVID A · 2015 to 2019
$1.9M
DEPENDENCE OF THERMOGENESIS AND BROWN ADIPOSE TISSUE FUNCTION ON FATP1 AND CD36R01DK089202 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI STAHL, ANDREAS · 2011 to 2015
$1.9M
Matrix assisted cell transplantation of brown fatR01DK101293 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI HEALY, KEVIN EDWARD, STAHL, ANDREAS · 2014 to 2017
$1.7M
CIHR MOP123387Intramural NIH HHS NIH0010513932NCI NIH HHS R01 CA196986NIDDK NIH HHS R01 DK089202NIDDK NIH HHS R01 DK094004NIDDK NIH HHS R01 DK101293
6 · The paper itself

Abstract

Despite progress in our comprehension of the mechanisms regulating adipose tissue development, the nature of the factors that functionally characterize adipose precursors is still elusive. Defining the early steps regulating adipocyte development is needed for the generation of tools to control adipose tissue size and function. Here, we report the discovery of V-set and transmembrane domain containing 2A (VSTM2A) as a protein expressed and secreted by committed preadipocytes. VSTM2A expression is elevated in the early phases of adipogenesis in vitro and adipose tissue development in vivo. We show that VSTM2A-producing cells associate with the vasculature and express the common surface markers of adipocyte progenitors. Overexpression of VSTM2A induces adipogenesis, whereas its depletion impairs this process. VSTM2A controls preadipocyte determination at least in part by modulating BMP signaling and PPARγ2 activation. We propose a model in which VSTM2A is produced to preserve and amplify the adipogenic capability of adipose precursors.

Indexed as

AdipogenesisCell Lineage3T3-L1 CellsAdipocytesAdipose Tissue, WhiteAnimalsBiomarkersBone Morphogenetic ProteinsCell DifferentiationGene Knockdown TechniquesHumansMaleMembrane ProteinsMesenchymal Stem CellsMiceMice, Inbred C57BLBiomarkersBone Morphogenetic ProteinsMembrane ProteinsPPAR gammaReceptors, ImmunologicVSTM2A protein, humanVSTM2 protein, mouse3T3-L1adipogenesisadipogenic commitmentadipose tissuecell differentiationcell signalingobesitypreadipocyte

Identifiers

PMID28052263
PMCPMC5551894
OpenAlexW2571392669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.